vs
Elme Communities（ELME）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Elme Communities的1.1倍（$69.8M vs $62.1M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -198.9%，领先582.9%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 1.7%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 2.7%）
Elme Communities是一家总部位于美国的上市房地产投资信托，主要持有、运营及开发高品质多户住宅项目，业务覆盖美国大西洋中部及东南部核心增长市场，为不同租户群体提供可负担及中档住宅选择。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ELME vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$62.1M
营收增速更快
RIGL
高出19.5%
1.7%
净利率更高
RIGL
高出582.9%
-198.9%
两年增速更快
RIGL
近两年复合增速
2.7%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $69.8M |
| 净利润 | $-123.5M | $268.1M |
| 毛利率 | 61.1% | 91.5% |
| 营业利润率 | -183.3% | 33.2% |
| 净利率 | -198.9% | 384.0% |
| 营收同比 | 1.7% | 21.2% |
| 净利润同比 | -4058.7% | 1769.2% |
| 每股收益（稀释后） | $-1.40 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELMERIGL
| Q4 25 | — | $69.8M | ||
| Q3 25 | $62.1M | $69.5M | ||
| Q2 25 | $62.1M | $101.7M | ||
| Q1 25 | $61.5M | $53.3M | ||
| Q4 24 | $61.3M | $57.6M | ||
| Q3 24 | $61.1M | $55.3M | ||
| Q2 24 | $60.1M | $36.8M | ||
| Q1 24 | $59.5M | $29.5M |
净利润ELMERIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $-123.5M | $27.9M | ||
| Q2 25 | $-3.6M | $59.6M | ||
| Q1 25 | $-4.7M | $11.4M | ||
| Q4 24 | $-3.0M | $14.3M | ||
| Q3 24 | $-3.0M | $12.4M | ||
| Q2 24 | $-3.5M | $-1.0M | ||
| Q1 24 | $-3.6M | $-8.2M |
毛利率ELMERIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | 61.1% | 93.2% | ||
| Q2 25 | 63.5% | 95.6% | ||
| Q1 25 | 64.2% | 91.7% | ||
| Q4 24 | 62.9% | 89.9% | ||
| Q3 24 | 63.5% | 85.5% | ||
| Q2 24 | 63.4% | 92.4% | ||
| Q1 24 | 63.5% | 93.1% |
营业利润率ELMERIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | -183.3% | 40.9% | ||
| Q2 25 | 9.6% | 60.1% | ||
| Q1 25 | 7.8% | 23.9% | ||
| Q4 24 | 10.4% | 28.9% | ||
| Q3 24 | 11.0% | 25.4% | ||
| Q2 24 | 9.8% | 1.2% | ||
| Q1 24 | 7.5% | -23.6% |
净利率ELMERIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | -198.9% | 40.2% | ||
| Q2 25 | -5.7% | 58.6% | ||
| Q1 25 | -7.6% | 21.5% | ||
| Q4 24 | -4.9% | 24.9% | ||
| Q3 24 | -4.9% | 22.5% | ||
| Q2 24 | -5.8% | -2.8% | ||
| Q1 24 | -6.1% | -27.9% |
每股收益（稀释后）ELMERIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | $-1.40 | $1.46 | ||
| Q2 25 | $-0.04 | $3.28 | ||
| Q1 25 | $-0.05 | $0.63 | ||
| Q4 24 | $-0.04 | $0.82 | ||
| Q3 24 | $-0.03 | $0.70 | ||
| Q2 24 | $-0.04 | $-0.06 | ||
| Q1 24 | $-0.04 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.1M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $908.9M | $391.5M |
| 总资产 | $1.7B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ELMERIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | $7.1M | $137.1M | ||
| Q2 25 | $4.8M | $108.4M | ||
| Q1 25 | $6.4M | $77.1M | ||
| Q4 24 | $6.1M | $77.3M | ||
| Q3 24 | $4.8M | $61.1M | ||
| Q2 24 | $5.6M | $49.1M | ||
| Q1 24 | $4.2M | $49.5M |
总债务ELMERIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益ELMERIGL
| Q4 25 | — | $391.5M | ||
| Q3 25 | $908.9M | $117.6M | ||
| Q2 25 | $1.0B | $81.9M | ||
| Q1 25 | $1.1B | $18.6M | ||
| Q4 24 | $1.1B | $3.3M | ||
| Q3 24 | $1.1B | $-14.6M | ||
| Q2 24 | $1.1B | $-29.9M | ||
| Q1 24 | $1.1B | $-31.7M |
总资产ELMERIGL
| Q4 25 | — | $513.6M | ||
| Q3 25 | $1.7B | $242.5M | ||
| Q2 25 | $1.8B | $206.7M | ||
| Q1 25 | $1.8B | $176.0M | ||
| Q4 24 | $1.8B | $164.0M | ||
| Q3 24 | $1.9B | $139.4M | ||
| Q2 24 | $1.9B | $128.4M | ||
| Q1 24 | $1.9B | $126.5M |
负债/权益比ELMERIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $7.2M | — |
| 自由现金流率自由现金流/营收 | 11.6% | — |
| 资本支出强度资本支出/营收 | 14.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $86.7M | — |
8季度趋势，按日历期对齐
经营现金流ELMERIGL
| Q4 25 | — | $22.0M | ||
| Q3 25 | $15.9M | $24.0M | ||
| Q2 25 | $29.8M | $30.5M | ||
| Q1 25 | $16.2M | $-893.0K | ||
| Q4 24 | $95.2M | $14.5M | ||
| Q3 24 | $20.7M | $21.7M | ||
| Q2 24 | $28.9M | $302.0K | ||
| Q1 24 | $21.2M | $-5.0M |
自由现金流ELMERIGL
| Q4 25 | — | — | ||
| Q3 25 | $7.2M | — | ||
| Q2 25 | $21.1M | — | ||
| Q1 25 | $10.5M | — | ||
| Q4 24 | $47.9M | — | ||
| Q3 24 | $8.8M | — | ||
| Q2 24 | $21.0M | — | ||
| Q1 24 | $7.6M | — |
自由现金流率ELMERIGL
| Q4 25 | — | — | ||
| Q3 25 | 11.6% | — | ||
| Q2 25 | 34.1% | — | ||
| Q1 25 | 17.1% | — | ||
| Q4 24 | 78.1% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 34.9% | — | ||
| Q1 24 | 12.8% | — |
资本支出强度ELMERIGL
| Q4 25 | — | — | ||
| Q3 25 | 14.0% | — | ||
| Q2 25 | 14.0% | — | ||
| Q1 25 | 9.2% | — | ||
| Q4 24 | 77.4% | — | ||
| Q3 24 | 19.4% | — | ||
| Q2 24 | 13.1% | — | ||
| Q1 24 | 22.9% | — |
现金转化率ELMERIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELME
| Residential Segment | $57.7M | 93% |
| Other | $4.4M | 7% |
RIGL
暂无分部数据
